Showing 24,461 - 24,480 results of 25,042 for search '"CD"', query time: 0.13s Refine Results
  1. 24461
  2. 24462
  3. 24463
  4. 24464
  5. 24465
  6. 24466

    Species Diversity, Biomass Production and Carbon Sequestration Potential in the Protected Area of Uttarakhand, India by Geetanjali Upadhyay, Lalit M. Tewari, Ashish Tewari, Naveen Chandra Pandey, Sheetal Koranga, Zishan Ahmad Wani, Geeta Tewari, Ravi K. Chaturvedi

    Published 2025-01-01
    “…Conversely, a negative correlation was found with the concentration of tree dominance (CD) (r<sup>2</sup> = 0.43). The <i>Quercus leucotrichophora</i>, <i>Rhododendron arboreum</i> and <i>Quercus floribunda</i> (QL-RA-QF) community(higher altitudinal zone) exhibited the highest tree biomass (568.8 Mg ha<sup>−1</sup>), while the (<i>Pinus roxburghii</i> and <i>Quercus leucotrichophora</i>) PR-QL (N) community (lower altitudinal zone) in the north aspect showed the lowest (265.7 Mg ha<sup>−1</sup>). …”
    Get full text
    Article
  7. 24467
  8. 24468
  9. 24469
  10. 24470
  11. 24471

    Signatures of H3K4me3 modification predict cancer immunotherapy response and identify a new immune checkpoint-SLAMF9 by Tao Fan, Chu Xiao, Ziqin Deng, Shuofeng Li, He Tian, Yujia Zheng, Bo Zheng, Chunxiang Li, Jie He

    Published 2025-01-01
    “…The mice melanoma model showed Slamf9 knockdown remarkably restrained cancer progression and enhanced the efficacy of anti-CTLA-4 and anti-PD-L1 therapies by elevating CD8 + T cell infiltration. This study provided a new H3K4me3-associated biomarker system to predict tumor immunotherapy response and suggested the preclinical rationale for investigating the roles of SLAMF9 in cancer immunity regulation and treatment.…”
    Get full text
    Article
  12. 24472

    PATHOLOGICAL CHANGES IN MICE TREATED WITH CYCLOPHOSPHAMIDE AND EXOGENOUS DNA by E. V. Dolgova, V. P. Nikolin, N. A. Popova, A. S. Proskurina, K. E. Orishchenko, E. A. Alyamkina, Ya. R. Efremov, S. I. Baiborodin, E. R. Chernykh, A. A. Ostanin, S. S. Bogachev, T. S. Gvozdeva, E. M. Malkova, O. S. Taranov, V. A. Rogachev, A. S. Panov, S. N. Zagrebelnyi, M. A. Shurdov

    Published 2014-12-01
    “…However, the relative amount of CD34+ hematopoietic stem cells (HSCs) from day 15 and till the end of the observation constituted 1,2–1,4 %, which corresponds to the wild-type range. …”
    Get full text
    Article
  13. 24473
  14. 24474
  15. 24475
  16. 24476
  17. 24477
  18. 24478
  19. 24479
  20. 24480

    Malignancies in people living with HIV: A 25-years observational study from a tertiary hospital in Italy by Antonio Anastasia, Walter Mazzucco, Luca Pipitò, Santo Fruscione, Roberta Gaudiano, Marcello Trizzino, Maurizio Zarcone, Antonio Cascio

    Published 2025-02-01
    “…No statistical difference was found between the mean values of zenith HIV-RNA and CD4 count in HIV outpatients with cancer and in those without cancer, while a statistically significant difference was found between the HIV-RNA zenith in HIV outpatients with ADC as compared with NADC (10.2 copies/mL versus 8.1 copies/mL; p-value= 0.007). …”
    Get full text
    Article